• xxx


Dr Luis Aznar-Garcia is currently working as a Consultant Clinical Oncologist at the Nottingham University Hospitals as Stereotactic Radiosurgery (SRS) and Brain Metastases MDT Lead Clinician. He is involved in Stereotactic Ablative Radiotherapy (SABR/SBRT) for Oligometastases, Hepatobilliary (HpB) tumours and breast cancer.

Dr Luis Aznar-Garcia has broad experience in the field of high advanced radiotherapy treatments. His main expertise is in the area of the Stereotactic Radiotherapy (SRS and SABR/SBRT), with vast professional experience using Gammknife, Cyberknife, Magnetic Resonance Image Guided Radiotherapy (MRL) and Linac-based platforms to treat metastatic disease as well as primary tumours. He has treated with Stereotactic techniques more than 1000 patients since 2001.

Dr Luis Aznar-Garcia has been Head of Radiotherapy Department at Leicester University Hospitals for 3 years and Head of Radiotherapy and Radiosurgery at Ruber International Hospital (Madrid, Spain) for 2 years. He has been a Clinical Oncologist Consultant for more than 20 years.

Dr Luis Aznar-Garcia is Honorary (Consultant) Assistant Professor at University of Nottingham.

He is a member of multiple National and International Oncological Societies (ESTRO, ISRS, ESMO, RCR, SEOR…).

Dr Luis Aznar-Garcia is Editor of several International Oncological Journals. He has published around 37 papers in International Medical Journals, books and meeting presentations.

Dr Luis Aznar-Garcia is Investigator in several Stereotactic Radiotherapy Trials (CORE, ABC-07, OligoRare, SARON, HALT, SPARC, SCALOP 2), some of them as Principal Investigator.

In addition, he has had a successful application to Genome England Clinical Interpretation Partnership (GeCIP).

UK Oncology Forum 2024

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.